Joincare Pharmaceutical Group Industry Co.,Ltd.

SSE:600380.SS

11.77 (CNY) • At close June 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 15,619.4816,646.3517,142.75315,903.68813,521.60611,980.15311,203.96410,779.2589,721.5448,641.8917,417.9066,219.8855,849.9614,791.5144,472.8583,683.2472,938.4872,498.5572,076.2042,488.9182,345.7981,752.426711.648678.818677.752487.466390.53316.546
Cost of Revenue 5,827.8536,298.4666,252.2655,716.2944,874.1874,270.7174,214.1514,008.1153,661.9633,426.9173,036.012,463.2742,823.4542,255.7961,906.4961,634.7931,440.11,248.718989.681,159.9511,020.335673.102185.797187.611183.331133.87797.91988.28
Gross Profit 9,791.62810,347.88510,890.48810,187.3948,647.4197,709.4366,989.8136,771.1436,059.5815,214.9754,381.8963,756.6113,026.5072,535.7182,566.3622,048.4541,498.3871,249.8391,086.5231,328.9671,325.4631,079.325525.851491.207494.422353.589292.611228.266
Gross Profit Ratio 0.6270.6220.6350.6410.640.6440.6240.6280.6230.6030.5910.6040.5170.5290.5740.5560.510.50.5230.5340.5650.6160.7390.7240.730.7250.7490.721
Reseach & Development Expenses 1,435.3521,661.7581,742.0881,397.1311,071.712905.591708.444528.162383.344299.987234.314186.354301.915000000000000000
General & Administrative Expenses 274.589368.667220.293293.662363.161337.115323.461314.412265.321244.783179.685198.173559.612484.205451.407390.199326.623335.71362.461442.129336.279239.2874.81159.56752.60240.72543.1721.864
Selling & Marketing Expenses 3,272.7933,932.4024,950.8025,026.8123,940.3373,962.1883,978.8593,963.7643,738.2463,138.782,742.6142,264.0031,781.8671,357.991998.6837.732630.975482.294604.228664.037739.714618.313298.622250.694283.893261.692176.993135.768
SG&A 3,547.3814,301.0695,171.0965,320.4744,303.4984,299.3024,302.3194,278.1774,003.5673,383.5632,922.2992,462.1762,341.481,842.1961,450.0071,227.932957.598818.005966.691,106.1661,075.993857.594373.433310.261336.496302.417220.162157.632
Other Expenses 1,192.611878.493682.069581.061501.984479.495167.54570.026143.186120.62268.44350.51351.00739.43515.94316.66910.712-1.085-32.6922.7223.0417.02150.8156.76957.08341.74932.87233.041
Operating Expenses 6,175.3446,841.327,595.2527,298.6675,877.1945,684.3885,449.0375,210.8344,906.4614,152.2573,507.9062,977.9172,413.751,899.8791,462.8661,235.308964.03823.23971.8071,112.4621,079.801861.459375.219311.365336.94302.588220.27157.677
Operating Income 3,616.2843,506.5653,479.9362,983.0672,972.9552,187.1381,594.2325,872.6651,039.073866.979733.723657.979503.477556.3021,101.501874.1-2.71,167.56588.658193.106197.951213.989154.834160.645122.35420.38845.63458.83
Operating Income Ratio 0.2320.2110.2030.1880.220.1830.1420.5450.1070.10.0990.1060.0860.1160.2460.237-0.0010.4670.0430.0780.0840.1220.2180.2370.1810.0420.1170.186
Total Other Income Expenses Net -41.397-41.01-23.831-30.737-22.795-9.038138.7767.717135.3114.36166.78949.932-20.22664.38615.10887.492-506.83767.471-51.565-23.705-51.4367.4451.41658.45448.80842.41433.42533.041
Income Before Tax 3,574.8873,465.5553,456.1052,952.3292,950.162,178.11,733.0025,940.3821,180.644981.34800.512707.911545.912593.8261,116.61889.4676.091,165.24450.216192.307193.651221.428206.25219.098179.95362.80279.05991.871
Income Before Tax Ratio 0.2290.2080.2020.1860.2180.1820.1550.5510.1210.1140.1080.1140.0930.1240.250.2410.0020.4660.0240.0770.0830.1260.290.3230.2660.1290.2020.29
Income Tax Expense 592.141614.536562.009339.48371.694328.082273.4021,267.651206.236159.547116.708136.419104.106102.787113.057104.93-18.902138.47640.71437.05538.39632.74834.62118.4815.1635.6076.5097.065
Net Income 1,386.571,442.782,894.0962,612.8492,578.4661,850.018699.4112,133.04451.415412.47354.239273.625169.522261.953740.047486.008-26.957725.072-77.441128.00997.263140.275171.882200.618164.79153.2558.61484.806
Net Income Ratio 0.0890.0870.1690.1640.1910.1540.0620.1980.0460.0480.0480.0440.0290.0550.1650.132-0.0090.29-0.0370.0510.0410.080.2420.2960.2430.1090.150.268
EPS 0.740.761.531.351.330.950.431.360.260.240.210.160.0990.150.420.28-0.0160.41-0.0460.0530.040.0580.0710.0830.0870.0310.0340.049
EPS Diluted 0.740.761.531.351.320.950.431.360.260.240.210.160.0990.150.420.28-0.0160.41-0.0460.0530.040.0580.0710.0830.0870.0310.0340.049
EBITDA 4,511.4675,013.1864,733.2183,702.8243,561.3232,809.7452,448.7576,604.1031,883.321,609.5791,343.9431,132.6151,032.039957.6981,377.8751,154.589329.7521,443.822316.862366.717333.278332.293257.747263.503220.82570.23872.34170.589
EBITDA Ratio 0.2890.3010.2760.2330.2630.2350.2190.6130.1940.1860.1810.1820.1760.20.3080.3130.1120.5780.1530.1470.1420.190.3620.3880.3260.1440.1850.223